| Page 1590 | Kisaco Research
 

Marie-Eve Beaulieu

CSO & Co-Founder
Peptomyc

Marie-Eve Beaulieu

CSO & Co-Founder
Peptomyc

Marie-Eve Beaulieu

CSO & Co-Founder
Peptomyc
 

Judith Frydman

Professor
Stanford University

Judith Frydman

Professor
Stanford University

Judith Frydman

Professor
Stanford University
 

Johanne Caplan

CDO
ProMIS Neurosciences

Johanne Caplan

CDO
ProMIS Neurosciences

Johanne Caplan

CDO
ProMIS Neurosciences
 

Alexander Scheer

CSO
Aelin Therapeutics

Alexander Scheer

CSO
Aelin Therapeutics

Alexander Scheer

CSO
Aelin Therapeutics
Human Biotechs and Animal Health
SPOTLIGHT FINALISTS 2020
 

Calan Smith

Director - Animal Health Portfolio
Kisaco Research

Head of Animal Health Portfolio at Kisaco Research for the last 5 years, Calan has developed the global investment partnering event series to become an industry standard and must attend for leadership teams around the globe, including start-ups, investors and multinationals.

With the primary responsibility for developing and driving an industry agenda that supports growth and innovation, most recently Calan and Kisaco have broadened the scope of our market intelligence offering to include both an international event series and a business intelligence reports. 

Calan Smith

Director - Animal Health Portfolio
Kisaco Research

Calan Smith

Director - Animal Health Portfolio
Kisaco Research

Head of Animal Health Portfolio at Kisaco Research for the last 5 years, Calan has developed the global investment partnering event series to become an industry standard and must attend for leadership teams around the globe, including start-ups, investors and multinationals.

With the primary responsibility for developing and driving an industry agenda that supports growth and innovation, most recently Calan and Kisaco have broadened the scope of our market intelligence offering to include both an international event series and a business intelligence reports. 

Quantum Partnerships Forum - Draft Agenda

Animal Health Industry Response to COVID-19 and the Rise of Telemedicine

  • Motivation

    The animal health industry in 2020 is experiencing a tectonic shift. While still feeling the lingering effects of the African Swine Fever virus, the industry is now faced with the personal and professional impact of a global COVID-19 pandemic, as well as a societal awakening in light of recent events in the United States, leading to the Black Lives Matter movement. The result has been an unprecedented level of accelerated change within the industry, leading to new directions and scenarios that we have outlined in this report.

Request a sample

Please complete the form below to receive a sample of this report.